Search

Isaac Shomer

Examiner (ID: 12146, Phone: (571)270-7671 , Office: P/1612 )

Most Active Art Unit
1612
Art Unit(s)
1612
Total Applications
1343
Issued Applications
756
Pending Applications
157
Abandoned Applications
491

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 15083273 [patent_doc_number] => 20190336447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-07 [patent_title] => LIPOSOME COMPOSITION AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 16/511380 [patent_app_country] => US [patent_app_date] => 2019-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16511380 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/511380
Liposome composition and method for producing same Jul 14, 2019 Issued
Array ( [id] => 16009057 [patent_doc_number] => 20200179371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => Stabilizing Camptothecin Pharmaceutical Compositions [patent_app_type] => utility [patent_app_number] => 16/510394 [patent_app_country] => US [patent_app_date] => 2019-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34490 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16510394 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/510394
Stabilizing Camptothecin Pharmaceutical Compositions Jul 11, 2019 Abandoned
Array ( [id] => 15990179 [patent_doc_number] => 20200170960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED NANOPARTICLES FOR THERAPY OF PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 16/505668 [patent_app_country] => US [patent_app_date] => 2019-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505668 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/505668
PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED NANOPARTICLES FOR THERAPY OF PROSTATE CANCER Jul 7, 2019 Abandoned
Array ( [id] => 15321213 [patent_doc_number] => 20200000936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-02 [patent_title] => BLOCK COPOLYMERS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/459039 [patent_app_country] => US [patent_app_date] => 2019-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12801 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16459039 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/459039
BLOCK COPOLYMERS AND USES THEREOF Jun 30, 2019 Abandoned
Array ( [id] => 16776587 [patent_doc_number] => 20210113664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCES [patent_app_type] => utility [patent_app_number] => 17/253078 [patent_app_country] => US [patent_app_date] => 2019-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11255 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253078 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/253078
IMPLANTS FOR RELEASE OF LIPOPHILIC OR AMPHIPHILIC PHARMACEUTICAL SUBSTANCES Jun 24, 2019 Pending
Array ( [id] => 15205927 [patent_doc_number] => 20190365650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-05 [patent_title] => TARGETED POLYMERIZED NANOPARTICLES FOR CANCER TREATMENT [patent_app_type] => utility [patent_app_number] => 16/444842 [patent_app_country] => US [patent_app_date] => 2019-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16444842 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/444842
Targeted polymerized nanoparticles for cancer treatment Jun 17, 2019 Issued
Array ( [id] => 15264909 [patent_doc_number] => 20190381188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => Nanoparticles For Crossing The Blood Brain Barrier And Methods Of Treatment Using The Same [patent_app_type] => utility [patent_app_number] => 16/438762 [patent_app_country] => US [patent_app_date] => 2019-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32507 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 289 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438762 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/438762
Nanoparticles For Crossing The Blood Brain Barrier And Methods Of Treatment Using The Same Jun 11, 2019 Abandoned
Array ( [id] => 18116294 [patent_doc_number] => 11547666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-10 [patent_title] => Cationic lipids comprising a steroidal moiety [patent_app_type] => utility [patent_app_number] => 17/058334 [patent_app_country] => US [patent_app_date] => 2019-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36506 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058334 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/058334
Cationic lipids comprising a steroidal moiety May 29, 2019 Issued
Array ( [id] => 16961641 [patent_doc_number] => 20210213140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => Phosphoester Cationic Lipids [patent_app_type] => utility [patent_app_number] => 17/058557 [patent_app_country] => US [patent_app_date] => 2019-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46611 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -86 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058557 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/058557
Phosphoester Cationic Lipids May 28, 2019 Abandoned
Array ( [id] => 15083235 [patent_doc_number] => 20190336428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-07 [patent_title] => Prebiotic Oral Care Methods Using a Saccharide [patent_app_type] => utility [patent_app_number] => 16/424927 [patent_app_country] => US [patent_app_date] => 2019-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16424927 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/424927
Prebiotic oral care methods using a saccharide May 28, 2019 Issued
Array ( [id] => 16138823 [patent_doc_number] => 10702465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-07 [patent_title] => Oral care formulation and method for the removal of tartar and plaque from teeth [patent_app_type] => utility [patent_app_number] => 16/422340 [patent_app_country] => US [patent_app_date] => 2019-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 22 [patent_no_of_words] => 17728 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16422340 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/422340
Oral care formulation and method for the removal of tartar and plaque from teeth May 23, 2019 Issued
Array ( [id] => 19120090 [patent_doc_number] => 11964051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-23 [patent_title] => Ribose cationic lipids [patent_app_type] => utility [patent_app_number] => 17/054886 [patent_app_country] => US [patent_app_date] => 2019-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 45362 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/054886
Ribose cationic lipids May 14, 2019 Issued
Array ( [id] => 14774739 [patent_doc_number] => 20190262267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-29 [patent_title] => PHARMACEUTICAL SOLUTION HAVING A TOXICITY-REDUCING EFFECT FOR ANTITUMOR DRUGS, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 16/407736 [patent_app_country] => US [patent_app_date] => 2019-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16407736 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/407736
Pharmaceutical solution having a toxicity-reducing effect for antitumor drugs, and pharmaceutical composition comprising same May 8, 2019 Issued
Array ( [id] => 14712481 [patent_doc_number] => 20190247304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => TREATING INFLAMMATION WITH INHALED ASPIRIN [patent_app_type] => utility [patent_app_number] => 16/396272 [patent_app_country] => US [patent_app_date] => 2019-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396272 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/396272
Treating inflammation with inhaled aspirin Apr 25, 2019 Issued
Array ( [id] => 16822547 [patent_doc_number] => 20210137840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => LIPID-BASED FORMULATIONS FOR THE DELIVERY OF RNA [patent_app_type] => utility [patent_app_number] => 17/050441 [patent_app_country] => US [patent_app_date] => 2019-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18372 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17050441 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/050441
LIPID-BASED FORMULATIONS FOR THE DELIVERY OF RNA Apr 24, 2019 Abandoned
Array ( [id] => 16822554 [patent_doc_number] => 20210137847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-13 [patent_title] => Nanoparticle comprising a bio-resorbable polyester, a hydrophilic polymer and an acylated human lactoferrin-derived peptide [patent_app_type] => utility [patent_app_number] => 17/052947 [patent_app_country] => US [patent_app_date] => 2019-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10374 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052947 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/052947
Nanoparticle comprising a bio-resorbable polyester, a hydrophilic polymer and an acylated human lactoferrin-derived peptide Apr 23, 2019 Issued
Array ( [id] => 15239367 [patent_doc_number] => 20190374469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-12 [patent_title] => APTAMER BIOCONJUGATE DRUG DELIVERY DEVICE [patent_app_type] => utility [patent_app_number] => 16/383998 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383998 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/383998
APTAMER BIOCONJUGATE DRUG DELIVERY DEVICE Apr 14, 2019 Abandoned
Array ( [id] => 14926243 [patent_doc_number] => 20190298759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => PLANT MEDIUM INCLUDING AN OXYGEN-ENABLED COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/384599 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384599 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/384599
Plant medium including an oxygen-enabled composition Apr 14, 2019 Issued
Array ( [id] => 16760948 [patent_doc_number] => 20210106529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => NANOLIPOSOME-MICROBUBBLE CONJUGATE INCLUDING DRUG FOR HAIR LOSS TREATMENT ENCAPSULATED IN NANOLIPOSOME AND COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS CONTAINING SAME [patent_app_type] => utility [patent_app_number] => 16/646887 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5092 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646887 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/646887
Nanoliposome-microbubble conjugate including drug for hair loss treatment encapsulated in nanoliposome and composition for alleviating or treating hair loss containing same Apr 10, 2019 Issued
Array ( [id] => 16718681 [patent_doc_number] => 20210085828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-25 [patent_title] => IMPLANTABLE CELL DRESSING FOR TREATMENT OF DISEASE [patent_app_type] => utility [patent_app_number] => 16/971430 [patent_app_country] => US [patent_app_date] => 2019-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971430 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/971430
Implantable cell dressing for treatment of disease Mar 21, 2019 Issued
Menu